<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02510092</url>
  </required_header>
  <id_info>
    <org_study_id>Im-CAD-001</org_study_id>
    <nct_id>NCT02510092</nct_id>
  </id_info>
  <brief_title>Coronary Artery and Systemic Autoimmune Disease: Diagnostics and Treatment</brief_title>
  <official_title>In Vivo Intravascular Diagnostics and Evaluation of New Therapeutic Modalities in Systemic Autoimmune and Coronary Artery Disease Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University Heart and Vascular Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Debrecen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Semmelweis University Heart and Vascular Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates in vivo intracoronary imaging using intravascular ultrasound and optical&#xD;
      coherence tomography and safety and efficacy of new generation fully bioresorbable vascular&#xD;
      scaffolds in four well defined systemic autoimmune (rheumatoid arthritis, mixed connective&#xD;
      tissue disease, systemic sclerosis, systemic lupus erythematosus) and concomitant coronary&#xD;
      disease patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to assess in vivo intracoronary anatomy using intravascular&#xD;
      ultrasound and optical coherence tomography and assess the efficacy and safety of new&#xD;
      generation fully bioresorbable vascular scaffolds in a systemic autoimmune and coronary heart&#xD;
      disease patient population.&#xD;
&#xD;
      The following four well defined systemic autoimmune entities are linked to increased&#xD;
      cardiovascular risk: rheumatoid arthritis, mixed connective tissue disease, systemic&#xD;
      sclerosis and systemic lupus erythematosus. One of the main causes of death in systemic&#xD;
      autoimmune subjects is cardiovascular disease. In-vivo intracoronary anatomy and pathology&#xD;
      regarding systemic autoimmune diseases is unknown. Furthermore, all forms of&#xD;
      revascularization in such patients yield sub-optimal results, with poor outcomes using even&#xD;
      the most modern drug eluting metallic stents. This may be linked to a long term exaggerated&#xD;
      chronic inflammation response to the metallic components. Thus, fully bioresorbable vascular&#xD;
      scaffolds may prove more efficacious in systemic autoimmune subjects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">March 2021</completion_date>
  <primary_completion_date type="Actual">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major adverse cardiac and cerebral events</measure>
    <time_frame>From index procedure to 5 years</time_frame>
    <description>Eligible for patients in clinical need for revascularization undergoing percutaneous revascularization with a bioresorbable vascular scaffold</description>
  </primary_outcome>
  <other_outcome>
    <measure>Intravascular ultrasound findings in coronaries</measure>
    <time_frame>At index procedure</time_frame>
    <description>Minimum Lumen Area (MLA)</description>
  </other_outcome>
  <other_outcome>
    <measure>Intravascular ultrasound findings in coronaries</measure>
    <time_frame>At index procedure</time_frame>
    <description>Percent Atheroma Volume (PAV)</description>
  </other_outcome>
  <other_outcome>
    <measure>Intravascular ultrasound findings in coronaries</measure>
    <time_frame>At index procedure</time_frame>
    <description>Area Stenosis (AS)</description>
  </other_outcome>
  <other_outcome>
    <measure>Intravascular ultrasound findings in coronaries</measure>
    <time_frame>At index procedure</time_frame>
    <description>Negative or positive remodelling index (RI)</description>
  </other_outcome>
  <other_outcome>
    <measure>Intravascular ultrasound findings in coronaries</measure>
    <time_frame>At index procedure</time_frame>
    <description>Intimal thickness (IT)</description>
  </other_outcome>
  <other_outcome>
    <measure>Intravascular ultrasound findings in coronaries</measure>
    <time_frame>At index procedure</time_frame>
    <description>Calcification Index (CI)</description>
  </other_outcome>
  <other_outcome>
    <measure>Optical coherence tomography findings in coronaries</measure>
    <time_frame>At index procedure</time_frame>
    <description>Intima to Media ratio (I/M ratio)</description>
  </other_outcome>
  <other_outcome>
    <measure>Optical coherence tomography findings in coronaries</measure>
    <time_frame>At index procedure</time_frame>
    <description>Excentric intima hyperplasia</description>
  </other_outcome>
  <other_outcome>
    <measure>Optical coherence tomography findings in coronaries</measure>
    <time_frame>At index procedure</time_frame>
    <description>Thin Cap Fibroatheroma presence (TCFA)</description>
  </other_outcome>
  <other_outcome>
    <measure>Optical coherence tomography findings in coronaries</measure>
    <time_frame>At index procedure</time_frame>
    <description>Macrophage infiltration</description>
  </other_outcome>
  <other_outcome>
    <measure>Optical coherence tomography findings in coronaries</measure>
    <time_frame>At index procedure</time_frame>
    <description>Intramural hematoma formation</description>
  </other_outcome>
  <other_outcome>
    <measure>Optical coherence tomography findings in coronaries</measure>
    <time_frame>At index procedure</time_frame>
    <description>Intimal laceration</description>
  </other_outcome>
  <other_outcome>
    <measure>Optical coherence tomography findings in coronaries</measure>
    <time_frame>At index procedure</time_frame>
    <description>Microchannel formation</description>
  </other_outcome>
  <other_outcome>
    <measure>Optical coherence tomography findings in coronaries</measure>
    <time_frame>At index procedure</time_frame>
    <description>Lipid pool formation</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Autoimmune Diseases</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Coronary artery diseae with revascularization indicated</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects with coronary artery disease, that require and are eligible for percutaneous revascularization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coronary artery disease not requiring revascularization</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects with coronary artery disease that do not require revascularization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percutaneous coronary intervention with new generation fully resorbable scaffold</intervention_name>
    <arm_group_label>Coronary artery diseae with revascularization indicated</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age of 18+ years&#xD;
&#xD;
          -  Signed and dated informed consent form&#xD;
&#xD;
          -  Manifest autoimmune disease, consisting either of: rheumatoid arthritis or systemic&#xD;
             lupus erythematosus or systemic sclerosis or mixed connective tissue disease under the&#xD;
             care of a clinical immunologist&#xD;
&#xD;
          -  Clinical indication for a coronary angiography as determined by a cardiologist&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age of 75+ years&#xD;
&#xD;
          -  Glomerular filtration rate of under 30 ml/min&#xD;
&#xD;
          -  Severely decreased left ventricular function (ejection fraction &lt;35%)&#xD;
&#xD;
          -  Pregnancy or nursing&#xD;
&#xD;
          -  Unclear immunological diagnosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Semmelweis University Heart and Vascular Center</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>July 23, 2015</study_first_submitted>
  <study_first_submitted_qc>July 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2015</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Autoimmune Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

